Journal article
Why Do Patients With Atrial Fibrillation Not Receive Warfarin?
Abstract
Atrial fibrillation (AF) is a growing public health problem associated with significant morbidity and mortality. Numerous randomized controlled trials of warfarin have conclusively demonstrated that long-term anticoagulation therapy can reduce the risk for stroke by approximately 68% per year in patients with nonvalvular AF, and even more in patients with valvular AF. However, available data show that of those patients with AF and no …
Authors
Bungard TJ; Ghali WA; Teo KK; McAlister FA; Tsuyuki RT
Journal
JAMA Internal Medicine, Vol. 160, No. 1, pp. 41–46
Publisher
American Medical Association (AMA)
Publication Date
January 10, 2000
DOI
10.1001/archinte.160.1.41
ISSN
2168-6106